Antidiabetic Potentiality of the Aqueous-Methanolic Extract of Seed of Swietenia mahagoni (L.)‎ Jacq. in Streptozotocin-Induced Diabetic Male Albino Rat : A Correlative and Evidence-Based Approach with Antioxidative and Antihyperlipidemic Activities

Abstract EN

Antidiabetic, antioxidative, and antihyperlipidemic activities of aqueous-methanolic (2 : 3) extract of Swietenia mahagoni (L.) Jacq.

(family Meliaceae) seed studied in streptozotocin-induced diabetic rats.

Feeding with seed extract (25 mg 0.25 mL distilled water−1100 gm b.w.−1rat−1 day−1) for 21 days to diabetic rat lowered the blood glucose level as well as the glycogen level in liver.

Moreover, activities of antioxidant enzymes like catalase, peroxidase, and levels of the products of free radicals like conjugated diene and thiobarbituric acid reactive substances in liver, kidney, and skeletal muscles were corrected towards the control after this extract treatment in this model.

Furthermore, the seed extract corrected the levels of serum urea, uric acid, creatinine, cholesterol, triglyceride, and lipoproteins towards the control level in this experimental diabetic model.

The results indicated the potentiality of the extract of S.

mahagoni seed for the correction of diabetes and its related complications like oxidative stress and hyperlipidemia.

The extract may be a good candidate for developing a safety, tolerable, and promising neutraceutical treatment for the management of diabetes.